Advanced search
Start date
Betweenand

Control of iron-dependent genotoxicity by desferrioxamine derivatives with high cell permeability

Grant number: 19/21435-1
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): March 01, 2020
Effective date (End): February 28, 2021
Field of knowledge:Health Sciences - Medicine
Principal researcher:Maria Teresa Machini
Grantee:Lucas Henrique de Castro Ah-Time
Home Institution: Instituto de Química (IQ). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

Iron overload is a debilitating condition for patients, leading to decreased quality of life. At the same time, iron is a crucial nutrient also for parasites and tumor cells. Iron chelators are high-affinity molecules that display several possibilities of clinical use: (I) reducing metal overload; (II) delivering toxic metals to selected targets; (III) scavenging essential metals from said targets. Desferrioxamine (DFO), a bacterial siderophore, was the first clinically approved iron chelator, displaying a high affinity for Fe(III). However, its use is hampered since it has low cell permeability and low gastrointestinal absorption. Our laboratory developed two DFO derivatives with high cell permeability, DFO-caffeine (DFCAF) and DFO-triphenylphosphonium (TPP-DFO), aimed at the blood-brain barrier and mitochondria, respectively. In this project, we intend to study the structure of the Fe(III) derivatives of both conjugates. Also, we plan to study the ability of the new chelators to mitigate iron-dependent genotoxicity.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.